From Hypothesis-generating to Decision-grade: Making Finerenone–spironolactone Comparisons in HFpEF Globally Implementable
Cardiovascular Drugs and Therapy · 2026-08 · 40 (4) · 1249-1250
DOI: 10.1007/s10557-026-07856-9 ↗Kurz gefasst
Leserbrief in der Zeitschrift Cardiovascular Drugs and Therapy, online erschienen am 09.03.2026. Verfasst von M Vijayasimha und 2 weiteren Autor:innen. Beteiligte Einrichtung: University Institute of Allied Health Science, Chandigarh University, Gharuan, Mohali, 140413, Punjab, India. vijaya.e19133@cumail.in. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- University Institute of Allied Health Science, Chandigarh University, Gharuan, Mohali, 140413, Punjab, India. vijaya.e19133@cumail.in.
- Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Medical Rd, Rohtak, Haryana, 124001, India.
- University Institute of Allied Health Science, Chandigarh University, Gharuan, Mohali, 140413, Punjab, India.
Zitieren
APA
Vijayasimha, M., Srikanth, M., & Singh, G. (2026). From Hypothesis-generating to Decision-grade: Making Finerenone–spironolactone Comparisons in HFpEF Globally Implementable. Cardiovascular Drugs and Therapy, 40(4), 1249-1250. https://doi.org/10.1007/s10557-026-07856-9
Vancouver
Vijayasimha M, Srikanth M, Singh G. From Hypothesis-generating to Decision-grade: Making Finerenone–spironolactone Comparisons in HFpEF Globally Implementable. Cardiovascular Drugs and Therapy. 2026;40(4):1249-1250. doi:10.1007/s10557-026-07856-9
BibTeX
@article{Vijayasimha2026,
author = {Vijayasimha, M and Srikanth, M and Singh, Gurjeet},
title = {From Hypothesis-generating to Decision-grade: Making Finerenone–spironolactone Comparisons in HFpEF Globally Implementable},
journal = {Cardiovascular Drugs and Therapy},
year = {2026},
volume = {40},
number = {4},
pages = {1249--1250},
doi = {10.1007/s10557-026-07856-9}
}
EUVIMED